Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2022; 47(2): 396-399


Pre-eclempsia: A cross sectional study conducted on multigravida females

Romaiza Maqsood, Maria Malik, Azhar Hayat, Iqra Shoukat, Mehwish Khalid, Warisha Altaf.




Abstract

Objective: To determine the frequency of pre-eclempsia among multigravida females.
Methodology: This descriptive cross sectional study was conducted in department of gynecology and obstetrics, Allama Iqbal Memorial Teaching Hospital, Sialkot from January 2021 to June 20201. Multigravida women with the parity of 2-4, with singleton pregnancy and having gestational age >20 weeks confirmed on ultrasound, were included in the study. Those having any chronic disease like hypertension, diabetes mellitus, chronic kidney disease, multi fetal pregnancy, smoking or drug addiction, history of congenital anomalies in previous children were excluded from the study. Female with blood pressure ≥140/90 mmHg and proteinuria of ≥1+ detected on dipstick method either with edema or without edema was diagnosed as pre-eclempsia. Data were analyzed using SPSS version 21.
Results: Total of 142 multigravida females were included in the study with mean age of 27.83±4.5 years. 41(28.8%) were para-2, 68(47.8%) were para-3 and 33(23.2%) were para-4. 82(57.7%) had gestational age

Key words: Multigravida, pre-eclempsia, proteinuria, hypertension.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.